However, epigenetic modifications of PDX1 reducing its activity could contribute to the development of type 2 diabetes since this transcription factor binds to the promoter of a large set of genes related to β-cell survival as well as insulin secretion. The gene discussed is PDX1; the disease is type 2 diabetes mellitus.